Nasdaq

Microbot Medical’s Self-Cleaning Shunt (SCS™) Clearly Demonstrated the Ability to Prevent Shunt Occlusion in a Follow-up In-vitro Laboratory Study

HINGHAM, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Having successfully concluded an independent in-vitro laboratory study and published the positive results earlier this year, the operational ...
Nasdaq

Microbot Medical Inc. Achieves Key Milestones in Preparation for LIBERTY® Endovascular Robotic System Launch

Microbot Medical Inc. announces key milestones, including FDA 510(k) submission, in preparation for LIBERTY's commercial launch in 2025. Microbot Medical Inc. announced the successful completion of ...
Seeking Alpha

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

HINGHAM, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY Endovascular Robotic System, today announced the continued expansion of its ...